Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...

The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.

If the FDA deems Pfizer’s and Moderna’s updated vaccines “new” products, it’s extremely unlikely the doses would be ready for ...

The Trump administration's effort to impose new requirements on Novavax's COVID-19 vaccine — the nation's only traditional ...

The head of the Food and Drug Administration said Tuesday that the agency is now looking at whether it will still approve COVID-19 vaccines for next winter, citing a lack of data on booster shots.

Researchers aim to develop a universal vaccine platform that could protect against both COVID-19 and influenza without annual ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

The Food and Drug Administration was set to release new guidance on COVID booster shots ahead of the fall season, but that's ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

A new randomized study could cost Novavax tens of millions of dollars, vaccine experts say ...

Federal regulators have asked Novavax to complete an additional clinical trial on its COVID-19 vaccine after previously ...